1. Volume 65, Issue 2, Pages 666-674 (February 2004)
Anticoagulant efficacy of PEG-Hirudin in patients on maintenance hemodialysis 
Katrin Annett Pöschel, Elke Bucha, Hans-ulrich Esslinger, Kristina Ulbricht, Peter Nörtersheuser, Günter Stein, Götz Nowak 
Kidney International 
Volume 65, Issue 2, Pages (February 2004)
DOI: /j x
Copyright © 2004 International Society of Nephrology Terms and Conditions

2. Figure 1
Mean (±2 SEM) effect-time course of activated partial thromboplastin time (aPTT) (seconds), Group II,N=10patients. S, start of sessions [hemodialysis (HD1-13); E, end of sessions (HD1-13). Anticoagulants: unfractionated heparin (UFH) for HD1-3, PEG-Hirudin for HD4-13. Blood sampling times for HD : prior to HD, at 5 minutes, 30 minutes, 1hour, 2hours, 3hours, and post-dialysis. Blood sampling times for HD2+3, HD5-7 and HD9-12: pre- and post-dialysis. The intradialytic intervals (from S to E) represent a mean duration of 4.3hours; the interdialytic intervals (from E to S) represent time periods of 2 or 3days.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

3. Figure 2
Ecarin clotting time (ECT) (A) and activated partial thromboplastin time (aPTT) (B) versus PEG-Hirudin plasma concentration relationship. The relationship between ECT and PEG-Hirudin, based on anti IIa-activity, can be described with sufficient accuracy (r = 0.91), whereas the relationship between aPTT and PEG-Hirudin is more variable (r = 0.56).
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions